REFERENCES
A. T. M. Serajuddin, P-C. Sheen, D. Mufson, D. F. Bernstein, and M. A. Augustine. Effect of vehicle amphiphilicity on the dissolution and bioavailability of a poorly water soluble drug from solid dispersions. J. Pharm. Sci. 77:414–417 (1988).
P-C. Sheen, S-I. Kim, J. J. Petillo, and A. T. M. Serajuddin. Bioavailability of a poorly water soluble drug from tablet and solid dispersion in humans. J. Pharm. Sci. 80:712–714 (1991).
N. H. Shah, M. T. Carjaval, C. I. Patel, M. H. Infeld, and A. W. Malick. Self-emulsifying drug delivery systems (SEDDS) for improving in vitro dissolution and oral absorption of lipophilic drugs. Bull. Tech. Gattefosse. 85:45–54 (1992–1993).
USP 23-NF 18; United States Pharmacopoeial Convention, Inc.: Rockville, MD, 1995.
J. R. Crison, N. D. Weiner, and G. L. Amidon. Dissolution media for in vitro testing of water soluble drugs: Effect of surfactant purity on in vitro dissolution of carbamazepine in aqueous solutions of sodium lauryl sulfate. J. Pharm. Sci. 87:384–388 (1997b).
J. S. Grundy, K. E. Anderson, J. A. Rogers, and R. T. Foster. Studies on dissolution testing of the nifedipine gastrointestinal therapeutic system. I Description of a two-phase in vitro dissolution test. J. Contr. Rel. 48:1–8 (1997).
V. Pillay and R. Fassihi. Evaluation and comparison of dissolution data derived from different modified release dosage forms: An alternative method. J. Contr. Rel. 55:45–55 (1998).
M. Gibaldi and S. Feldman. Establishment of sink conditions in dissolution rate determinations. J. Pharm. Sci. 56:1238–1242 (1967).
Center for Drug Evaluation and Research (CDER) at the Food and Drug Administration (FDA). Guidance for industry: Dissolution testing of immediate release solid oral dosage forms, SUPAC-IR (1997).
J. W. Moore and H. H. Flanner. Mathematical comparison of dissolution profiles. Pharm. Tech. 20:64–74 (1996).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pillay, V., Fassihi, R. A New Method for Dissolution Studies of Lipid-Filled Capsules Employing Nifedipine as a Model Drug. Pharm Res 16, 333–337 (1999). https://doi.org/10.1023/A:1011959914706
Issue Date:
DOI: https://doi.org/10.1023/A:1011959914706